Crossref
Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.113815 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Sylwia Tabor und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tabor, S., & Piwowarczyk, M. (2026). Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.113815
Vancouver
Tabor S, Piwowarczyk M. Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.113815
BibTeX
@article{Tabor2026,
author = {Tabor, Sylwia and Piwowarczyk, Mikołaj},
title = {Pembrolizumab monotherapy for locally advanced non-small cell lung cancer in a patient living with human immunodeficiency virus},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.113815}
}
EUVIMED